246 related articles for article (PubMed ID: 35794775)
1. Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-Analysis.
Yang M; Wang C; Zhao G; Kong D; Liu L; Yuan S; Chen W; Feng C; Li Z
Curr Neuropharmacol; 2023; 21(2):340-352. PubMed ID: 35794775
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study.
Liu H; Yu R; Gao Y; Li X; Guan X; Thomas K; Xiu M; Zhang X
Curr Neuropharmacol; 2022 Aug; 20(9):1774-1782. PubMed ID: 34544343
[TBL] [Abstract][Full Text] [Related]
3. Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs.
Tsai MC; Liou CW; Lin TK; Lin IM; Huang TL
Psychiatry Res; 2013 Oct; 209(3):284-90. PubMed ID: 23497820
[TBL] [Abstract][Full Text] [Related]
4. Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.
Bai ZL; Li XS; Chen GY; Du Y; Wei ZX; Chen X; Zheng GE; Deng W; Cheng Y
J Mol Neurosci; 2018 Nov; 66(3):428-436. PubMed ID: 30298298
[TBL] [Abstract][Full Text] [Related]
5. Altered Antioxidant Defenses in Drug-Naive First Episode Patients with Schizophrenia Are Associated with Poor Treatment Response to Risperidone: 12-Week Results from a Prospective Longitudinal Study.
Li XR; Xiu MH; Guan XN; Wang YC; Wang J; Leung E; Zhang XY
Neurotherapeutics; 2021 Apr; 18(2):1316-1324. PubMed ID: 33791970
[TBL] [Abstract][Full Text] [Related]
6. Decreased Activity of Erythrocyte Catalase and Glutathione Peroxidase in Patients with Schizophrenia.
Djordjević VV; Kostić J; Krivokapić Ž; Krtinić D; Ranković M; Petković M; Ćosić V
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295651
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics.
Padurariu M; Ciobica A; Dobrin I; Stefanescu C
Neurosci Lett; 2010 Aug; 479(3):317-20. PubMed ID: 20561936
[TBL] [Abstract][Full Text] [Related]
9. Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis.
Goh XX; Tang PY; Tee SF
Psychiatry Res; 2022 Mar; 309():114429. PubMed ID: 35150976
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia.
Dakhale GN; Khanzode SD; Khanzode SS; Saoji A
Psychopharmacology (Berl); 2005 Nov; 182(4):494-8. PubMed ID: 16133138
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant intervention attenuates oxidative stress in children and teenagers with Down syndrome.
Parisotto EB; Garlet TR; Cavalli VL; Zamoner A; da Rosa JS; Bastos J; Micke GA; Fröde TS; Pedrosa RC; Wilhelm Filho D
Res Dev Disabil; 2014 Jun; 35(6):1228-36. PubMed ID: 24685938
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of oxidative stress markers in schizophrenia.
Zhang M; Zhao Z; He L; Wan C
Sci China Life Sci; 2010 Jan; 53(1):112-124. PubMed ID: 20596963
[TBL] [Abstract][Full Text] [Related]
13. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.
Sarandol A; Kirli S; Akkaya C; Altin A; Demirci M; Sarandol E
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1164-9. PubMed ID: 17459548
[TBL] [Abstract][Full Text] [Related]
14. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with osteoarthritis.
Surapaneni KM; Venkataramana G
Indian J Med Sci; 2007 Jan; 61(1):9-14. PubMed ID: 17197733
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress biomarkers in treatment-responsive and treatment-resistant schizophrenia patients.
Buosi P; Borghi FA; Lopes AM; Facincani IDS; Fernandes-Ferreira R; Oliveira-Brancati CIF; do Carmo TS; Souza DRS; da Silva DGH; de Almeida EA; de Araújo Filho GM
Trends Psychiatry Psychother; 2021; 43(4):278-285. PubMed ID: 34982515
[TBL] [Abstract][Full Text] [Related]
16. Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis.
Goh XX; Tang PY; Tee SF
Asian J Psychiatr; 2022 Jan; 67():102932. PubMed ID: 34839098
[TBL] [Abstract][Full Text] [Related]
17. Comparative effect of pioglitazone, quercetin and hydroxy citric acid on the status of lipid peroxidation and antioxidants in experimental non-alcoholic steatohepatitis.
Surapaneni KM; Jainu M
J Physiol Pharmacol; 2014 Feb; 65(1):67-74. PubMed ID: 24622831
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls.
Jiménez-Fernández S; Gurpegui M; Garrote-Rojas D; Gutiérrez-Rojas L; Carretero MD; Correll CU
Bipolar Disord; 2021 Mar; 23(2):117-129. PubMed ID: 32780547
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in schizophrenia patients treated with long-acting haloperidol decanoate.
Bošković M; Grabnar I; Terzič T; Kores Plesničar B; Vovk T
Psychiatry Res; 2013 Dec; 210(3):761-8. PubMed ID: 24041751
[TBL] [Abstract][Full Text] [Related]
20. Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia.
Wei C; Sun Y; Chen N; Chen S; Xiu M; Zhang X
Psychoneuroendocrinology; 2020 Jan; 111():104473. PubMed ID: 31655452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
